These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Can you provide a table of equivalences for benzodiazepines and other marketed benzodiazepine receptor agonists? Shader RI; Greenblatt DJ J Clin Psychopharmacol; 1997 Aug; 17(4):331. PubMed ID: 9241022 [No Abstract] [Full Text] [Related]
3. Additional generics on the market. FDA Drug Bull; 1986 Nov; 16(2):14-5. PubMed ID: 3817341 [No Abstract] [Full Text] [Related]
12. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule. Food and Drug Administration, HHS Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102 [TBL] [Abstract][Full Text] [Related]
13. Aspects for bioavailability and bioequivalence revision: possible implications on clinical pharmacology. Ritschel WA Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):453-9. PubMed ID: 3683020 [No Abstract] [Full Text] [Related]
14. Doctors are pivotal to prescription struggle. Chapman S Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688 [No Abstract] [Full Text] [Related]
16. [The mechanism of action of benzodiazepine and its consequences for therapy]. Cugurra F Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239 [TBL] [Abstract][Full Text] [Related]
17. Aspects of bioavailability and bioequivalence revision: possible implications on clinical pharmacology. Glasser AC Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):449-52. PubMed ID: 3683019 [No Abstract] [Full Text] [Related]
18. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. Weintraub M; Singh S; Byrne L; Maharaj K; Guttmacher L NIDA Res Monogr; 1993; 131():279-93. PubMed ID: 8105386 [No Abstract] [Full Text] [Related]
19. [The pharmacokinetic characteristics of fenazepam in epileptics]. Maksutova EL; Sariev AK; Zherdev VP; Voronina TA; Zheleznova EV Eksp Klin Farmakol; 1994; 57(2):16-8. PubMed ID: 7911365 [TBL] [Abstract][Full Text] [Related]
20. New approach in bioavailability study of two formulations of ethyl loflazepate. Ba BB; Iliadis A; Durand A; Berger Y; Cano JP Arzneimittelforschung; 1988 Oct; 38(10):1486-9. PubMed ID: 2904268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]